23andMe is ending its cancer research program and slashing over 200 jobs
23andMe is ending its cancer research program and slashing over 200 jobs
/ The genetic testing firm plans to license or sel… [read more]
23andMe is ending its cancer research program and slashing over 200 jobs
23andMe is ending its cancer research program and slashing over 200 jobs
/ The genetic testing firm plans to license or sel… [read more]